SMARThealth India: A stepped-wedge, cluster randomised controlled trial of a community health worker managed mobile health intervention for people assessed at high cardiovascular disease risk in rural India
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cardiovascular diseases (CVD) are rising in India resulting in major health system challenges. METHODS: Eighteen primary health centre (PHC) clusters in rural Andhra Pradesh were randomised over three, 6-month steps to an intervention comprising: (1) household CVD risk assessments by village-based community health workers (CHWs) using a mobile tablet device; (2) electronic referral and clinical decision support for PHC doctors; and (3) a tracking system for follow-up care. Independent data collectors screened people aged ≥ 40 years in 54 villages serviced by the PHCs to create a high CVD risk cohort (based on WHO risk charts and blood pressure thresholds). Randomly selected, independent samples, comprising 15% of this cohort, were reviewed at each 6-month step. The primary outcome was the proportion meeting systolic blood pressure (SBP) targets (<140mmHg). FINDINGS: Eight-four percent of the eligible population (n = 62,254) were assessed at baseline (18.4% at high CVD risk). Of those at high risk, 75.3% were followed up over two years. CHWs screened 85.9% of the baseline cohort and doctors followed up 70.0% of all high risk referrals. There was no difference in the proportion of people achieving SBP targets (41.2% vs 39.2%; adjusted odds ratio (OR) 1.01 95% CI 0.76-1.35) or receiving BP-lowering medications in the intervention vs control periods respectively. There was a high discordance in risk scores generated by independent data collectors and CHWs, resulting in only 37.2% of the evaluation cohort exposed to the intervention. This discordance was mainly driven by fluctuating BP values (both normal variability and marked seasonal variations). In the pre-specified high risk concordant subgroup, there was greater use of BP-lowering medications in the intervention period (54.3% vs 47.9%, OR 1.22, 95% CI 1.03-1.44) but no impact on BP control. CONCLUSIONS: The strategy was well implemented with increased treatment rates among high risk individuals assessed by CHWs, however effects on BP were not demonstrated. Use of guideline-recommended BP thresholds for identifying high risk individuals substantially affected the reproducibility of risk assessment, and thus the ability to reliably evaluate the effectiveness of the intervention. In addition, unanticipated seasonal variation in BP in the context of a stepped-wedge trial highlights the inherent risks of this study design. TRIAL REGISTRATION: Clinical Trials Registry of India CTRI/2013/06/ 003753.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anchala, R., Kannuri, N. K., Pant, H., Khan, H., Franco, O. H., Di Angelantonio, E., & Prabhakaran, D. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000146 · Cited by 782
Self-citationJoshi, R., Alim, M., Kengne, A. P., Jan, S., Maulik, P. K., Peiris, D., & Patel, A. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103754 · Cited by 589 · cited 1×
“[11, 12] Currently, rural primary health care is delivered at a Primary Health Centre (PHC) facility which is usually led by one doctor and services around 30,000 residents from the surrounding villages and nurse/ midwife level care is provided at sub-centres which support around 3000–5000 people.”
BackgroundSelf-citationPraveen, D., Patel, A., Raghu, A., Clifford, G. D., Maulik, P. K., Mohammad Abdul, A., Mogulluru, K., Tarassenko, L., MacMahon, S., & Peiris, D. (2014) · JMIR mHealth and uHealth · doi:10.2196/mhealth.3568 · Cited by 131
Self-citationJoshi, R., Chow, C. K., Raju, P. K., Raju, R., Reddy, K. S., MacMahon, S., Lopez, A. D., & Neal, B. (2009) · Circulation · doi:10.1161/circulationaha.108.819201 · Cited by 67
Self-citation
Cited by
Understanding the rise of cardiometabolic diseases in low- and middle-income countries
Miranda, J. J., Barrientos-Gutiérrez, T., Corvalan, C., Hyder, A. A., Lazo-Porras, M., Oni, T., & Wells, J. C. K. (2019) · Nature Medicine · doi:10.1038/s41591-019-0644-7 · Cited by 365
A Community-Based Intervention for Managing Hypertension in Rural South Asia
Jafar, T. H., Gandhi, M., de Silva, H. A., Jehan, I., Naheed, A., Finkelstein, E. A., Turner, E. L., Morisky, D., Kasturiratne, A., Khan, A. H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911965 · Cited by 303
Schwalm, J.-D., McCready, T., Lopez-Jaramillo, P., Yusoff, K., Attaran, A., Lamelas, P., Camacho, P. A., Majid, F., Bangdiwala, S. I., Thabane, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31949-x · Cited by 274
Saif‐Ur‐Rahman, K., Islam, M. S., Alaboson, J., Ola, O., Hasan, I., Islam, N., Mainali, S., Martina, T., Silenga, E., Muyangana, M., et al. (2023) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12547 · Cited by 56
“18,19,26,27 For instance, compared to the baselines and between intervention and control groups, there was no change in the mean systolic blood pressure in hypertensive people, 27 and neonatal mortality rose from 4.5 to 6.4 deaths per 1000 deliveries in intervention and 3.9 to 4.3 deaths per 1000…”
InfluentialNagraj, S., Kennedy, S. H., Norton, R., Jha, V., Praveen, D., Hinton, L., & Hirst, J. E. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00040 · Cited by 21
“Important areas for future research would be to conduct adequately sized, robustly designed trials, demonstrating tangible impact upon mortality across the lifecourse, including cost effectiveness analyses, and exploration of the impact of climate change and seasonal variations on BPrelated endpoints (57, 58).”
BackgroundSelf-citation
Metadata
- Authors
- Peiris, D., Praveen, D., Mogulluru, K., Ameer, M. A., Raghu, A., Li, Q., Heritier, S., MacMahon, S., Prabhakaran, D., Clifford, G. D., Joshi, R., Maulik, P. K., Jan, S., Tarassenko, L., & Patel, A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-03-26
- Volume
- 14
- Issue
- 3
- Pages
- e0213708
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2924610085
- Cited by
- 84
- References
- 5
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.